{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T21:13:42Z","timestamp":1790975622886,"version":"4.1.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:00:00Z","timestamp":1773273600000},"content-version":"vor","delay-in-days":15,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["P.R.I.N.2022-PNRR (P2022BWAJN_002)"],"award-info":[{"award-number":["P.R.I.N.2022-PNRR (P2022BWAJN_002)"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["P.R.I.N.2022-PNRR P2022T7FXB_002"],"award-info":[{"award-number":["P.R.I.N.2022-PNRR P2022T7FXB_002"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["P.R.I.N.2022-PNRR P2022WARR8"],"award-info":[{"award-number":["P.R.I.N.2022-PNRR P2022WARR8"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["P.R.I.N. (2022Y79PT4)"],"award-info":[{"award-number":["P.R.I.N. (2022Y79PT4)"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021856","name":"Ministero dell'Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["P.R.I.N 202243KSPJ"],"award-info":[{"award-number":["P.R.I.N 202243KSPJ"]}],"id":[{"id":"10.13039\/501100021856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["PNRR- MISSIONE 6 - Progetto PNRR-POC-2023-12377405 -BEN-HuR- Codice Cup I63C24000340006"],"award-info":[{"award-number":["PNRR- MISSIONE 6 - Progetto PNRR-POC-2023-12377405 -BEN-HuR- Codice Cup I63C24000340006"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-07915-7","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T17:35:47Z","timestamp":1772040947000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["NGF-mediated tumor\u2013stroma crosstalk promotes prostate cancer aggressiveness"],"prefix":"10.1186","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7207-826X","authenticated-orcid":false,"given":"Marzia","family":"Di Donato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Giovannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"De Sio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antimo","family":"Migliaccio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Castoria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"7915_CR1","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1016\/j.euo.2024.07.003","volume":"8","author":"C Bangma","year":"2025","unstructured":"Bangma C, Doan P, Zhu L, Remmers S, Nieboer D, Helleman J, et al. Has active surveillance for prostate cancer become safer? Lessons learned from a global clinical registry. Eur Urol Oncol. 2025;8:324\u201337. https:\/\/doi.org\/10.1016\/j.euo.2024.07.003.","journal-title":"Eur Urol Oncol"},{"key":"7915_CR2","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12967-022-03861-2","volume":"21","author":"PV Nuzzo","year":"2023","unstructured":"Nuzzo PV, Pederzoli F, Saieva C, Zanardi E, Fotia G, Malgeri A, et al. Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer. J Transl Med. 2023;21:75. https:\/\/doi.org\/10.1186\/s12967-022-03861-2.","journal-title":"J Transl Med"},{"key":"7915_CR3","doi-asserted-by":"publisher","unstructured":"Mehralivand S, Thomas C, Puhr M, Claessens F, van de Merbel AF, Dubrovska A, et al. New advances of the androgen receptor in prostate cancer: report from the 1st international androgen receptor symposium. J Transl Med. 2024;22:71. https:\/\/doi.org\/10.1186\/s12967-024-04878-5.","DOI":"10.1186\/s12967-024-04878-5"},{"key":"7915_CR4","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1186\/s12967-020-02281-4","volume":"18","author":"Y Lin","year":"2020","unstructured":"Lin Y, Zhao X, Miao Z, Ling Z, Wei X, Pu J, et al. Data-driven translational prostate cancer research: from biomarker discovery to clinical decision. J Transl Med. 2020;18:119. https:\/\/doi.org\/10.1186\/s12967-020-02281-4.","journal-title":"J Transl Med"},{"key":"7915_CR5","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3322\/caac.70020","volume":"75","author":"D Chakrabarti","year":"2025","unstructured":"Chakrabarti D, Albertsen P, Adkins A, Kishan A, Murthy V, Parker C, et al. The contemporary management of prostate cancer. CA Cancer J Clin. 2025;75:552\u201386. https:\/\/doi.org\/10.3322\/caac.70020.","journal-title":"CA Cancer J Clin"},{"key":"7915_CR6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2022.01.015","volume":"530","author":"J Kang","year":"2022","unstructured":"Kang J, La Manna F, Bonollo F, Sampson N, Alberts IL, Mingels C, et al. Tumor microenvironment mechanisms and bone metastatic disease progression of prostate cancer. Cancer Lett. 2022;530:156\u201369. https:\/\/doi.org\/10.1016\/j.canlet.2022.01.015.","journal-title":"Cancer Lett"},{"key":"7915_CR7","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1186\/s12967-024-05564-2","volume":"22","author":"E Di Carlo","year":"2024","unstructured":"Di Carlo E, Sorrentino C. The multifaceted role of the stroma in the healthy prostate and prostate cancer. J Transl Med. 2024;22:825. https:\/\/doi.org\/10.1186\/s12967-024-05564-2.","journal-title":"J Transl Med"},{"key":"7915_CR8","doi-asserted-by":"publisher","first-page":"102395","DOI":"10.1016\/j.xcrm.2025.102395","volume":"6","author":"V Boeker","year":"2025","unstructured":"Boeker V, Kalluri R. Insights into the relevance of targeting fibroblasts to control cancer. Cell Rep Med. 2025;6:102395. https:\/\/doi.org\/10.1016\/j.xcrm.2025.102395.","journal-title":"Cell Rep Med"},{"key":"7915_CR9","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1186\/s12967-025-06744-4","volume":"23","author":"Y Li","year":"2025","unstructured":"Li Y, Wang L, Ma W, Wu J, Wu Q, Sun C. Paracrine signaling in cancer-associated fibroblasts: central regulators of the tumor immune microenvironment. J Transl Med. 2025;23:697. https:\/\/doi.org\/10.1186\/s12967-025-06744-4.","journal-title":"J Transl Med"},{"key":"7915_CR10","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12967-024-06022-9","volume":"23","author":"L Tang","year":"2025","unstructured":"Tang L, Chen X, Hou J, Wei X. CXCL14 in prostate cancer: complex interactions in the tumor microenvironment and future prospects. J Transl Med. 2025;23:9. https:\/\/doi.org\/10.1186\/s12967-024-06022-9.","journal-title":"J Transl Med"},{"key":"7915_CR11","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s12967-023-04807-y","volume":"22","author":"W Wang","year":"2024","unstructured":"Wang W, Li T, Xie Z, Zhao J, Zhang Y, Ruan Y, et al. Integrating single-cell and bulk RNA sequencing data unveils antigen presentation and process-related CAFS and establishes a predictive signature in prostate cancer. J Transl Med. 2024;22:57. https:\/\/doi.org\/10.1186\/s12967-023-04807-y.","journal-title":"J Transl Med"},{"key":"7915_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1002\/jez.1401160206","volume":"116","author":"R Levi-Montalcini","year":"1951","unstructured":"Levi-Montalcini R, Hamburger V. Selective growth stimulating effects of mouse sarcoma on the sensory and sympathetic nervous system of the chick embryo. J Exp Zool. 1951;116:321\u201361. https:\/\/doi.org\/10.1002\/jez.1401160206.","journal-title":"J Exp Zool"},{"key":"7915_CR13","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1002\/jnr.490320402","volume":"32","author":"T Ebendal","year":"1992","unstructured":"Ebendal T. Function and evolution in the NGF family and its receptors. J Neurosci Res. 1992;32:461\u201370. https:\/\/doi.org\/10.1002\/jnr.490320402.","journal-title":"J Neurosci Res"},{"key":"7915_CR14","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1186\/1479-5876-10-239","volume":"10","author":"L Aloe","year":"2012","unstructured":"Aloe L, Rocco ML, Bianchi P, Manni L. Nerve growth factor: from the early discoveries to the potential clinical use. J Transl Med. 2012;10:239. https:\/\/doi.org\/10.1186\/1479-5876-10-239.","journal-title":"J Transl Med"},{"key":"7915_CR15","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1016\/j.cell.2023.02.002","volume":"186","author":"F Winkler","year":"2023","unstructured":"Winkler F, Venkatesh HS, Amit M, Batchelor T, Demir IE, Deneen B, et al. Cancer neuroscience: state of the field, emerging directions. Cell. 2023;186:1689\u2013707. https:\/\/doi.org\/10.1016\/j.cell.2023.02.002.","journal-title":"Cell"},{"key":"7915_CR16","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","volume":"41","author":"D Hanahan","year":"2023","unstructured":"Hanahan D, Monje M. Cancer hallmarks intersect with neuroscience in the tumor microenvironment. Cancer Cell. 2023;41:573\u201380. https:\/\/doi.org\/10.1016\/j.ccell.2023.02.012.","journal-title":"Cancer Cell"},{"key":"7915_CR17","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1002\/dneu.20767","volume":"70","author":"LC Schecterson","year":"2010","unstructured":"Schecterson LC, Bothwell M. Neurotrophin receptors: old friends with new partners. Dev Neurobiol. 2010;70:332\u20138. https:\/\/doi.org\/10.1002\/dneu.20767.","journal-title":"Dev Neurobiol"},{"key":"7915_CR18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13578-023-01008-4","volume":"13","author":"M Di Donato","year":"2023","unstructured":"Di Donato M, Giovannelli P, Migliaccio A, Castoria G. The nerve growth factor-delivered signals in prostate cancer and its associated microenvironment: when the dialogue replaces the monologue. Cell Biosci. 2023;13:60. https:\/\/doi.org\/10.1186\/s13578-023-01008-4.","journal-title":"Cell Biosci"},{"key":"7915_CR19","doi-asserted-by":"publisher","first-page":"152425","DOI":"10.1016\/j.seminoncol.2025.152425","volume":"53","author":"D Sigorski","year":"2025","unstructured":"Sigorski D, Kasprzyk-Pawelec A, Michalak M, Sosnowski R, Hryciuk MM, Sejda A, et al. The nervous system in prostate cancer: a basic science and clinical perspective. Semin Oncol. 2025;53:152425. https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152425.","journal-title":"Semin Oncol"},{"key":"7915_CR20","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1038\/s41419-021-03402-7","volume":"12","author":"M Di Donato","year":"2021","unstructured":"Di Donato M, Zamagni A, Galasso G, Di Zazzo E, Giovannelli P, Barone MV, et al. The androgen receptor\/filamin A complex as a target in prostate cancer microenvironment. Cell Death Dis. 2021;12:127. https:\/\/doi.org\/10.1038\/s41419-021-03402-7.","journal-title":"Cell Death Dis"},{"key":"7915_CR21","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1091\/mbc.E14-09-1352","volume":"26","author":"M Di Donato","year":"2015","unstructured":"Di Donato M, Bilancio A, D\u2019Amato L, Claudiani P, Oliviero MA, Barone MV, et al. Cross-talk between androgen receptor\/filamin A and TrkA regulates neurite outgrowth in PC12 cells. Mol Biol Cell. 2015;26:2858\u201372. https:\/\/doi.org\/10.1091\/mbc.E14-09-1352.","journal-title":"Mol Biol Cell"},{"key":"7915_CR22","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nprot.2016.006","volume":"11","author":"J Drost","year":"2016","unstructured":"Drost J, Karthaus WR, Gao D, Driehuis E, Sawyers CL, Chen Y, et al. Organoid culture systems for prostate epithelial and cancer tissue. Nat Protoc. 2016;11:347\u201358. https:\/\/doi.org\/10.1038\/nprot.2016.006.","journal-title":"Nat Protoc"},{"key":"7915_CR23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/cancers11060784","volume":"11","author":"M Di Donato","year":"2019","unstructured":"Di Donato M, Cernera G, Migliaccio A, Castoria G. Nerve growth factor induces proliferation and aggressiveness. Prostate Cancer Cells Cancers (Basel). 2019;11:784. https:\/\/doi.org\/10.3390\/cancers11060784.","journal-title":"Prostate Cancer Cells Cancers (Basel)"},{"key":"7915_CR24","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1038\/s41388-020-01615-2","volume":"40","author":"L Yin","year":"2021","unstructured":"Yin L, Li J, Wang J, Pu T, Wei J, Li Q, et al. MAOA promotes prostate cancer cell perineural invasion through SEMA3C\/PlexinA2\/NRP1-cMET signaling. Oncogene. 2021;40:1362\u201374. https:\/\/doi.org\/10.1038\/s41388-020-01615-2.","journal-title":"Oncogene"},{"key":"7915_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bbcan.2016.05.003","volume":"1866","author":"IE Demir","year":"2016","unstructured":"Demir IE, Tieftrunk E, Schorn S, Friess H, Ceyhan GO. Nerve growth factor & TrkA as novel therapeutic targets in cancer. Biochim Biophys Acta. 2016;1866:37\u201350. https:\/\/doi.org\/10.1016\/j.bbcan.2016.05.003.","journal-title":"Biochim Biophys Acta"},{"key":"7915_CR26","doi-asserted-by":"publisher","first-page":"bio030817","DOI":"10.1242\/bio.030817","volume":"7","author":"JC Kasemeier-Kulesa","year":"2018","unstructured":"Kasemeier-Kulesa JC, Romine MH, Morrison JA, Bailey CM, Welch DR, Kulesa PM. NGF reprograms metastatic melanoma to a bipotent glial-melanocyte neural crest-like precursor. Biol Open. 2018;7:bio030817. https:\/\/doi.org\/10.1242\/bio.030817.","journal-title":"Biol Open"},{"key":"7915_CR27","first-page":"161","volume":"14","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Dang C, Ma Q, Shimahara Y. Expression of nerve growth factor receptors and their prognostic value in human pancreatic cancer. Oncol Rep. 2005;14:161\u201371.","journal-title":"Oncol Rep"},{"key":"7915_CR28","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s11060-008-9682-6","volume":"91","author":"X Valderrama","year":"2009","unstructured":"Valderrama X, Rapin N, Verge VMK, Misra V. Zhangfei induces the expression of the nerve growth factor receptor, trkA, in medulloblastoma cells and causes their differentiation or apoptosis. J Neurooncol. 2009;91:7\u201317. https:\/\/doi.org\/10.1007\/s11060-008-9682-6.","journal-title":"J Neurooncol"},{"key":"7915_CR29","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1002\/(sici)1096-911x","volume":"31","author":"A Nakagawara","year":"1998","unstructured":"Nakagawara A. The NGF story and neuroblastoma. Med Pediatr Oncol. 1998;31:113\u20135. https:\/\/doi.org\/10.1002\/(sici)1096-911x. (199808)31:2%253C113::aid-mpo14%253E3.0.co;2-o.","journal-title":"Med Pediatr Oncol"},{"issue":"19980801","key":"7915_CR30","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1002\/(sici)1097-0045","volume":"36","author":"DJ George","year":"1998","unstructured":"George DJ, Suzuki H, Bova GS, Isaacs JT. Mutational analysis of the TrkA gene in prostate cancer. Prostate. 1998;36(19980801):172\u201380. https:\/\/doi.org\/10.1002\/(sici)1097-0045)36:3%253C172::aid-pros5%253E3.0.co;2-j.","journal-title":"Prostate"},{"issue":"199810","key":"7915_CR31","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/(sici)1098-2744","volume":"23","author":"B Pflug","year":"1998","unstructured":"Pflug B, Djakiew D. Expression of p75NTR in a human prostate epithelial tumor cell line reduces nerve growth factor-induced cell growth by activation of programmed cell death. Mol Carcinog. 1998;23(199810):106\u201314. https:\/\/doi.org\/10.1002\/(sici)1098-2744)23:2%253C106::aid-mc7%253E3.0.co;2-w.","journal-title":"Mol Carcinog"},{"key":"7915_CR32","doi-asserted-by":"publisher","first-page":"17864","DOI":"10.1074\/jbc.M010499200","volume":"276","author":"S Descamps","year":"2001","unstructured":"Descamps S, Toillon RA, Adriaenssens E, Pawlowski V, Cool SM, Nurcombe V, et al. Nerve growth factor stimulates proliferation and survival of human breast cancer cells through two distinct signaling pathways. J Biol Chem. 2001;276:17864\u201370. https:\/\/doi.org\/10.1074\/jbc.M010499200.","journal-title":"J Biol Chem"},{"key":"7915_CR33","doi-asserted-by":"publisher","first-page":"16659","DOI":"10.1074\/jbc.273.27.16659","volume":"273","author":"S Descamps","year":"1998","unstructured":"Descamps S, Lebourhis X, Delehedde M, Boilly B, Hondermarck H. Nerve growth factor is mitogenic for cancerous but not normal human breast epithelial cells. J Biol Chem. 1998;273:16659\u201362. https:\/\/doi.org\/10.1074\/jbc.273.27.16659.","journal-title":"J Biol Chem"},{"key":"7915_CR34","first-page":"4337","volume":"61","author":"S Descamps","year":"2001","unstructured":"Descamps S, Pawlowski V, R\u00e9villion F, Hornez L, Hebbar M, Boilly B, et al. Expression of nerve growth factor receptors and their prognostic value in human breast cancer. Cancer Res. 2001;61:4337\u201340.","journal-title":"Cancer Res"},{"key":"7915_CR35","first-page":"1211","volume":"5","author":"S Sigala","year":"1999","unstructured":"Sigala S, Faraoni I, Botticini D, Paez-Pereda M, Missale C, Bonmassar E, et al. Suppression of telomerase, reexpression of KAI1, and abrogation of tumorigenicity by nerve growth factor in prostate cancer cell lines. Clin Cancer Res. 1999;5:1211\u20138.","journal-title":"Clin Cancer Res"},{"key":"7915_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.10160","volume":"98","author":"S Krygier","year":"2002","unstructured":"Krygier S, Djakiew D. Neurotrophin receptor p75(NTR) suppresses growth and nerve growth factor-mediated metastasis of human prostate cancer cells. Int J Cancer. 2002;98:1\u20137. https:\/\/doi.org\/10.1002\/ijc.10160.","journal-title":"Int J Cancer"},{"key":"7915_CR37","first-page":"1924","volume":"8","author":"SJ Miknyoczki","year":"2002","unstructured":"Miknyoczki SJ, Wan W, Chang H, Dobrzanski P, Ruggeri BA, Dionne CA, et al. The neurotrophin-trk receptor axes are critical for the growth and progression of human prostatic carcinoma and pancreatic ductal adenocarcinoma xenografts in nude mice. Clin Cancer Res. 2002;8:1924\u201331.","journal-title":"Clin Cancer Res"},{"key":"7915_CR38","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2174\/1568009043332853","volume":"4","author":"L Doll\u00e9","year":"2004","unstructured":"Doll\u00e9 L, Adriaenssens E, El Yazidi-Belkoura I, Le Bourhis X, Nurcombe V, Hondermarck H. Nerve growth factor receptors and signaling in breast cancer. Curr Cancer Drug Targets. 2004;4:463\u201370. https:\/\/doi.org\/10.2174\/1568009043332853.","journal-title":"Curr Cancer Drug Targets"},{"key":"7915_CR39","doi-asserted-by":"publisher","first-page":"5592","DOI":"10.1038\/sj.onc.1206805","volume":"22","author":"L Doll\u00e9","year":"2003","unstructured":"Doll\u00e9 L, El Yazidi-Belkoura I, Adriaenssens E, Nurcombe V, Hondermarck H. Nerve growth factor overexpression and autocrine loop in breast cancer cells. Oncogene. 2003;22:5592\u2013601. https:\/\/doi.org\/10.1038\/sj.onc.1206805.","journal-title":"Oncogene"},{"key":"7915_CR40","doi-asserted-by":"publisher","unstructured":"Doll\u00e9 L, Oliveira M-J, Bruyneel E, Hondermarck H, Bracke M. Nerve growth factor mediates its pro-invasive effect in parallel with the release of a soluble E-cadherin fragment from breast cancer MCF-7\/AZ cells. J Dairy Res. 2005;72:Spec 20\u20136. https:\/\/doi.org\/10.1017\/s0022029905001160.\u00a0","DOI":"10.1017\/s0022029905001160"},{"key":"7915_CR41","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1517\/13543784.16.3.303","volume":"16","author":"AG Papatsoris","year":"2007","unstructured":"Papatsoris AG, Liolitsa D, Deliveliotis C. Manipulation of the nerve growth factor network in prostate cancer. Expert Opin Investig Drugs. 2007;16:303\u20139. https:\/\/doi.org\/10.1517\/13543784.16.3.303.","journal-title":"Expert Opin Investig Drugs"},{"key":"7915_CR42","first-page":"193","volume":"30","author":"C Festuccia","year":"2007","unstructured":"Festuccia C, Muzi P, Gravina GL, Millimaggi D, Speca S, Dolo V, et al. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1\/NGF receptor and limits the invasive capability of prostate cancer cells in vitro. Int J Oncol. 2007;30:193\u2013200.","journal-title":"Int J Oncol"},{"key":"7915_CR43","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/pros.20884","volume":"69","author":"C Festuccia","year":"2009","unstructured":"Festuccia C, Gravina GL, Muzi P, Millimaggi D, Dolo V, Vicentini C, et al. Her2 crosstalks with TrkA in a subset of prostate cancer cells: rationale for a guided dual treatment. Prostate. 2009;69:337\u201345. https:\/\/doi.org\/10.1002\/pros.20884.","journal-title":"Prostate"},{"key":"7915_CR44","doi-asserted-by":"publisher","first-page":"2446","DOI":"10.1210\/en.2012-2249","volume":"154","author":"V Anagnostopoulou","year":"2013","unstructured":"Anagnostopoulou V, Pediaditakis I, Alkahtani S, Alarifi SA, Schmidt E-M, Lang F, et al. Differential effects of dehydroepiandrosterone and testosterone in prostate and colon cancer cell apoptosis: the role of nerve growth factor (NGF) receptors. Endocrinology. 2013;154:2446\u201356. https:\/\/doi.org\/10.1210\/en.2012-2249.","journal-title":"Endocrinology"},{"key":"7915_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41420-017-0024-3","volume":"4","author":"M Di Donato","year":"2018","unstructured":"Di Donato M, Cernera G, Auricchio F, Migliaccio A, Castoria G. Cross-talk between androgen receptor and nerve growth factor receptor in prostate cancer cells: implications for a new therapeutic approach. Cell Death Discov. 2018;4:5. https:\/\/doi.org\/10.1038\/s41420-017-0024-3.","journal-title":"Cell Death Discov"},{"key":"7915_CR46","doi-asserted-by":"publisher","first-page":"676568","DOI":"10.3389\/fcell.2021.676568","volume":"9","author":"M Di Donato","year":"2021","unstructured":"Di Donato M, Galasso G, Giovannelli P, Sinisi AA, Migliaccio A, Castoria G. Targeting the nerve growth factor signaling impairs the proliferative and migratory phenotype of triple-negative breast cancer cells. Front Cell Dev Biol. 2021;9:676568. https:\/\/doi.org\/10.3389\/fcell.2021.676568.","journal-title":"Front Cell Dev Biol"},{"key":"7915_CR47","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1186\/s12967-024-05413-2","volume":"22","author":"M Talia","year":"2024","unstructured":"Talia M, Cesario E, Cirillo F, Scordamaglia D, Di Dio M, Zicarelli A, et al. Cancer-associated fibroblasts (CAFs) gene signatures predict outcomes in breast and prostate tumor patients. J Transl Med. 2024;22:597. https:\/\/doi.org\/10.1186\/s12967-024-05413-2.","journal-title":"J Transl Med"},{"key":"7915_CR48","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12967-025-06071-8","volume":"23","author":"S Zhou","year":"2025","unstructured":"Zhou S, Zhao Z, Wang Z, Xu H, Li Y, Xu K, et al. Cancer-associated fibroblasts in carcinogenesis. J Transl Med. 2025;23:50. https:\/\/doi.org\/10.1186\/s12967-025-06071-8.","journal-title":"J Transl Med"},{"key":"7915_CR49","doi-asserted-by":"publisher","first-page":"e009910","DOI":"10.1136\/jitc-2024-009910","volume":"12","author":"P Yang","year":"2024","unstructured":"Yang P, Chen X, Yu F, Wang L, Li M, Bai Z, et al. CAR T cells secreting NGF-neutralizing scFv enhance efficacy in clear cell renal cell carcinoma by relieving immunosuppression through immunosympathectomy. J Immunother Cancer. 2024;12:e009910. https:\/\/doi.org\/10.1136\/jitc-2024-009910.","journal-title":"J Immunother Cancer"},{"key":"7915_CR50","doi-asserted-by":"publisher","first-page":"8950","DOI":"10.3390\/cimb45110562","volume":"45","author":"S Terracina","year":"2023","unstructured":"Terracina S, Ferraguti G, Tarani L, Fanfarillo F, Tirassa P, Ralli M, et al. Nerve growth factor and autoimmune diseases. Curr Issues Mol Biol. 2023;45:8950\u201373. https:\/\/doi.org\/10.3390\/cimb45110562.","journal-title":"Curr Issues Mol Biol"},{"key":"7915_CR51","doi-asserted-by":"publisher","first-page":"965","DOI":"10.3390\/cimb46020062","volume":"46","author":"G Ferraguti","year":"2024","unstructured":"Ferraguti G, Terracina S, Tarani L, Fanfarillo F, Allushi S, Caronti B, et al. Nerve growth factor and the role of inflammation in tumor development. Current Issues in Molecular Biology. Multidisciplinary Digit Publishing Inst. 2024;46:965\u201389. https:\/\/doi.org\/10.3390\/cimb46020062.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"7915_CR52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/s12967-022-03827-4","volume":"21","author":"S Han","year":"2023","unstructured":"Han S, Shi T, Liao Y, Chen D, Yang F, Wang M, et al. Tumor immune contexture predicts recurrence after prostatectomy and efficacy of androgen deprivation and immunotherapy in prostate cancer. J Transl Med. 2023;21:194. https:\/\/doi.org\/10.1186\/s12967-022-03827-4.","journal-title":"J Transl Med"},{"key":"7915_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1002\/cac2.12392","volume":"43","author":"Z Fang","year":"2023","unstructured":"Fang Z, Meng Q, Xu J, Wang W, Zhang B, Liu J, et al. Signaling pathways in cancer-associated fibroblasts: recent advances and future perspectives. Cancer Commun. 2023;43:3\u201341. https:\/\/doi.org\/10.1002\/cac2.12392.","journal-title":"Cancer Commun"},{"key":"7915_CR54","doi-asserted-by":"publisher","first-page":"2778","DOI":"10.1038\/s41388-018-0609-1","volume":"38","author":"X Yang","year":"2019","unstructured":"Yang X, Shen H, Buckley B, Chen Y, Yang N, Mussell AL, et al. NTRK1 is a positive regulator of YAP oncogenic function. Oncogene. 2019;38:2778\u201387. https:\/\/doi.org\/10.1038\/s41388-018-0609-1.","journal-title":"Oncogene"},{"key":"7915_CR55","doi-asserted-by":"publisher","first-page":"166540","DOI":"10.1016\/j.bbadis.2022.166540","volume":"1868","author":"T Shen","year":"2022","unstructured":"Shen T, Li Y, Wang D, Su Y, Li G, Shang Z, et al. YAP1-TEAD1 mediates the perineural invasion of prostate cancer cells induced by cancer-associated fibroblasts. Biochim Biophys Acta Mol Basis Dis. 2022;1868:166540. https:\/\/doi.org\/10.1016\/j.bbadis.2022.166540.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"7915_CR56","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00262-010-0934-x","volume":"60","author":"RJ Warrington","year":"2011","unstructured":"Warrington RJ, Lewis KE. Natural antibodies against nerve growth factor inhibit in vitro prostate cancer cell metastasis. Cancer Immunol Immunother. 2011;60:187\u201395. https:\/\/doi.org\/10.1007\/s00262-010-0934-x.","journal-title":"Cancer Immunol Immunother"},{"key":"7915_CR57","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s42003-020-01549-1","volume":"4","author":"W-Y Chen","year":"2021","unstructured":"Chen W-Y, Wen Y-C, Lin S-R, Yeh H-L, Jiang K-C, Chen W-H, et al. Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance. Commun Biol. 2021;4:22. https:\/\/doi.org\/10.1038\/s42003-020-01549-1.","journal-title":"Commun Biol"},{"key":"7915_CR58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.20517\/jtgg.2024.15","volume":"8","author":"R Thomas","year":"2024","unstructured":"Thomas R, Jerome JM, Krieger KL, Ashraf N, Rowley DR. The reactive stroma response regulates the immune landscape in prostate cancer. jtgg. OAE Publishing Inc. 2024;8:249\u201377. https:\/\/doi.org\/10.20517\/jtgg.2024.15.","journal-title":"OAE Publishing Inc"},{"key":"7915_CR59","doi-asserted-by":"publisher","first-page":"694","DOI":"10.37349\/etat.2022.00108","volume":"3","author":"MT Palano","year":"2022","unstructured":"Palano MT, Gallazzi M, Cucchiara M, Deh\u00f2 F, Capogrosso P, Bruno A, et al. The tumor innate immune microenvironment in prostate cancer: an overview of soluble factors and cellular effectors. Explor Target Antitumor Ther. 2022;3:694\u2013718. https:\/\/doi.org\/10.37349\/etat.2022.00108.","journal-title":"Explor Target Antitumor Ther"},{"key":"7915_CR60","doi-asserted-by":"publisher","first-page":"102255","DOI":"10.1016\/j.tranon.2024.102255","volume":"52","author":"C Ding","year":"2025","unstructured":"Ding C, Wang J, Wang J, Niu J, Xiahou Z, Sun Z, et al. Heterogeneity of cancer-associated fibroblast subpopulations in prostate cancer: Implications for prognosis and immunotherapy. Translational Oncol. 2025;52:102255. https:\/\/doi.org\/10.1016\/j.tranon.2024.102255.","journal-title":"Translational Oncol"},{"key":"7915_CR61","doi-asserted-by":"publisher","unstructured":"Repasky E, Mohammadpour H. Targeting nerve growth factor: an Achilles\u2019 heel for tumors? J Immunother Cancer. 2025;13. https:\/\/doi.org\/10.1136\/jitc-2025-011609.","DOI":"10.1136\/jitc-2025-011609"},{"key":"7915_CR62","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/s10020-025-01333-z","volume":"31","author":"F Xiong","year":"2025","unstructured":"Xiong F, Xiao B, Wang Q, Liu K, Wu H, Jing C, et al. Nerve growth factor: what can surgeons and oncologists learn from a neurological and psychological biomarker? Mol Med. 2025;31:276. https:\/\/doi.org\/10.1186\/s10020-025-01333-z.","journal-title":"Mol Med"},{"key":"7915_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/imm.12717","volume":"151","author":"SD Skaper","year":"2017","unstructured":"Skaper SD. Nerve growth factor: a neuroimmune crosstalk mediator for all seasons. Immunology. 2017;151:1\u201315. https:\/\/doi.org\/10.1111\/imm.12717.","journal-title":"Immunology"},{"key":"7915_CR64","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1177\/1073858416687249","volume":"23","author":"SD Skaper","year":"2017","unstructured":"Skaper SD, Facci L, Zusso M, Giusti P, Neuroinflammation. Mast Cells, and Glia: Dangerous Liaisons. Neuroscientist. 2017;23:478\u201398. https:\/\/doi.org\/10.1177\/1073858416687249.","journal-title":"Neuroscientist"},{"key":"7915_CR65","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.3390\/ijms18051028","volume":"18","author":"G Minnone","year":"2017","unstructured":"Minnone G, De Benedetti F, Bracci-Laudiero L. NGF and its receptors in the regulation of inflammatory response. Int J Mol Sci Multidisciplinary Digit Publishing Inst. 2017;18:1028. https:\/\/doi.org\/10.3390\/ijms18051028.","journal-title":"Int J Mol Sci Multidisciplinary Digit Publishing Inst"},{"key":"7915_CR66","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/s41590-023-01723-7","volume":"25","author":"T Yin","year":"2024","unstructured":"Yin T, Wang G, Wang L, Mudgal P, Wang E, Pan CC, et al. Breaking NGF-TrkA immunosuppression in melanoma sensitizes immunotherapy for durable memory T cell protection. Nat Immunol. 2024;25:268\u201381. https:\/\/doi.org\/10.1038\/s41590-023-01723-7.","journal-title":"Nat Immunol"},{"key":"7915_CR67","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1186\/s12967-024-05824-1","volume":"22","author":"G Zeng","year":"2024","unstructured":"Zeng G, Yu Y, Wang M, Liu J, He G, Yu S, et al. Advancing cancer research through organoid technology. J Transl Med. 2024;22:1007. https:\/\/doi.org\/10.1186\/s12967-024-05824-1.","journal-title":"J Transl Med"},{"key":"7915_CR68","doi-asserted-by":"publisher","first-page":"688794","DOI":"10.3389\/fonc.2021.688794","volume":"11","author":"L Wang","year":"2021","unstructured":"Wang L, Li J, Wang R, Chen H, Wang R, Wang W, et al. NGF Signaling Interacts with the hippo\/YAP pathway to regulate cervical cancer progression. Front Oncol. 2021;11:688794. https:\/\/doi.org\/10.3389\/fonc.2021.688794.","journal-title":"Front Oncol"},{"key":"7915_CR69","doi-asserted-by":"publisher","first-page":"100305","DOI":"10.1016\/j.crbiot.2025.100305","volume":"10","author":"M Catalano","year":"2025","unstructured":"Catalano M, Landini L, Nozzoli F, Nassini R, Roviello G, De Logu F. Unraveling the role of perineural invasion in cancer-associated pain: Insights and treatment strategies. Curr Res Biotechnol. 2025;10:100305. https:\/\/doi.org\/10.1016\/j.crbiot.2025.100305.","journal-title":"Curr Res Biotechnol"},{"key":"7915_CR70","doi-asserted-by":"publisher","first-page":"2200039","DOI":"10.1002\/adbi.202200039","volume":"6","author":"A Mukherjee","year":"2022","unstructured":"Mukherjee A, Ha P, Wai KC, Naara S. The role of ECM remodeling, EMT, and adhesion molecules in cancerous neural invasion: changing perspectives. Adv Biology. 2022;6:2200039. https:\/\/doi.org\/10.1002\/adbi.202200039.","journal-title":"Adv Biology"},{"key":"7915_CR71","doi-asserted-by":"publisher","first-page":"1499414","DOI":"10.3389\/fphar.2024.1499414","volume":"15","author":"F Trentini","year":"2024","unstructured":"Trentini F, Agnetti V, Manini M, Giovannetti E, Garajov\u00e1 I. NGF-mediated crosstalk: unraveling the influence of metabolic deregulation on the interplay between neural and pancreatic cancer cells and its impact on patient outcomes. Front Pharmacol. 2024;15:1499414. https:\/\/doi.org\/10.3389\/fphar.2024.1499414.","journal-title":"Front Pharmacol"},{"key":"7915_CR72","doi-asserted-by":"publisher","first-page":"9807","DOI":"10.18632\/oncotarget.3227","volume":"6","author":"L Aubert","year":"2015","unstructured":"Aubert L, Guilbert M, Corbet C, G\u00e9not E, Adriaenssens E, Chassat T, et al. NGF-induced TrkA\/CD44 association is involved in tumor aggressiveness and resistance to lestaurtinib. Oncotarget Impact Journals. 2015;6:9807\u201319. https:\/\/doi.org\/10.18632\/oncotarget.3227.","journal-title":"Oncotarget Impact Journals"},{"key":"7915_CR73","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/s40779-025-00661-9","volume":"12","author":"Q-Q Liu","year":"2025","unstructured":"Liu Q-Q, Dong Z-K, Wang Y-F, Jin W-L. Reprogramming neural-tumor crosstalk: emerging therapeutic dimensions and targeting strategies. Mil Med Res. 2025;12:73. https:\/\/doi.org\/10.1186\/s40779-025-00661-9.","journal-title":"Mil Med Res"},{"key":"7915_CR74","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/(SICI)1097","volume":"38","author":"WE Farnsworth","year":"1999","unstructured":"Farnsworth WE. Prostate Stroma: Physiology. Prostate. 1999;38:60\u201372. https:\/\/doi.org\/10.1002\/(SICI)1097. -0045(19990101)38:1%253C60::AID-PROS8%253E3.0.CO;2-3.","journal-title":"Prostate"},{"key":"7915_CR75","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.diff.2018.08.005","volume":"103","author":"GR Cunha","year":"2018","unstructured":"Cunha GR, Vezina CM, Isaacson D, Ricke WA, Timms BG, Cao M, et al. Development of the human prostate. Differentiation. 2018;103:24\u201345. https:\/\/doi.org\/10.1016\/j.diff.2018.08.005.","journal-title":"Differentiation"},{"key":"7915_CR76","doi-asserted-by":"crossref","unstructured":"Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol. 2001;166(6):2472\u201383.","DOI":"10.1016\/S0022-5347(05)65620-0"},{"key":"7915_CR77","doi-asserted-by":"publisher","first-page":"R187","DOI":"10.1530\/ERC-12-0085","volume":"19","author":"DA Barron","year":"2012","unstructured":"Barron DA, Rowley DR. The reactive stroma microenvironment and prostate cancer progression. Endocrine-Related Cancer Soc Endocrinol. 2012;19:R187\u2013204. https:\/\/doi.org\/10.1530\/ERC-12-0085.","journal-title":"Endocrine-Related Cancer Soc Endocrinol"},{"key":"7915_CR78","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/s41559-020-1157-y","volume":"4","author":"Z Frankenstein","year":"2020","unstructured":"Frankenstein Z, Basanta D, Franco OE, Gao Y, Javier RA, Strand DW, et al. Stromal reactivity differentially drives tumour cell evolution and prostate cancer progression. Nat Ecol Evol Nat Publishing Group. 2020;4:870\u201384. https:\/\/doi.org\/10.1038\/s41559-020-1157-y.","journal-title":"Nat Ecol Evol Nat Publishing Group"},{"key":"7915_CR79","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","volume":"315","author":"HF Dvorak","year":"1986","unstructured":"Dvorak HF. Tumors: Wounds That Do Not Heal N Engl. J Med. 1986;315:1650\u20139. https:\/\/doi.org\/10.1056\/NEJM198612253152606.","journal-title":"J Med"},{"key":"7915_CR80","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.jtv.2009.11.004","volume":"20","author":"B Li","year":"2011","unstructured":"Li B, Wang JH-C. Fibroblasts and myofibroblasts in wound healing: Force generation and measurement. J Tissue Viability. 2011;20:108\u201320. https:\/\/doi.org\/10.1016\/j.jtv.2009.11.004.","journal-title":"J Tissue Viability"},{"key":"7915_CR81","doi-asserted-by":"publisher","first-page":"618","DOI":"10.4161\/cbt.6.4.4255","volume":"6","author":"A Orimo","year":"2007","unstructured":"Orimo A, Weinberg RA. Heterogeneity of stromal fibroblasts in tumor. Cancer Biology Therapy Taylor Francis. 2007;6:618\u20139. https:\/\/doi.org\/10.4161\/cbt.6.4.4255.","journal-title":"Cancer Biology Therapy Taylor Francis"},{"key":"7915_CR82","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.canlet.2021.10.028","volume":"525","author":"S ChallaSivaKanaka","year":"2022","unstructured":"ChallaSivaKanaka S, Vickman RE, Kakarla M, Hayward SW, Franco OE. Fibroblast heterogeneity in prostate carcinogenesis. Cancer Lett. 2022;525:76\u201383. https:\/\/doi.org\/10.1016\/j.canlet.2021.10.028.","journal-title":"Cancer Lett"},{"key":"7915_CR83","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1038\/nrc.2016.73","volume":"16","author":"R Kalluri","year":"2016","unstructured":"Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer Nat Publishing Group. 2016;16:582\u201398. https:\/\/doi.org\/10.1038\/nrc.2016.73.","journal-title":"Nat Rev Cancer Nat Publishing Group"},{"key":"7915_CR84","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/pros.23929","volume":"80","author":"RE Vickman","year":"2020","unstructured":"Vickman RE, Broman MM, Lanman NA, Franco OE, Sudyanti PAG, Ni Y, et al. Heterogeneity of human prostate carcinoma-associated fibroblasts implicates a role for subpopulations in myeloid cell recruitment. Prostate. 2020;80:173\u201385. https:\/\/doi.org\/10.1002\/pros.23929.","journal-title":"Prostate"},{"key":"7915_CR85","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1038\/ncomms2766","volume":"4","author":"Y Jung","year":"2013","unstructured":"Jung Y, Kim JK, Shiozawa Y, Wang J, Mishra A, Joseph J, et al. Recruitment of mesenchymal stem cells into prostate tumours promotes metastasis. Nat Commun Nat Publishing Group. 2013;4:1795. https:\/\/doi.org\/10.1038\/ncomms2766.","journal-title":"Nat Commun Nat Publishing Group"},{"key":"7915_CR86","doi-asserted-by":"publisher","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","volume":"67","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 2007;67:10123\u20138. https:\/\/doi.org\/10.1158\/0008-5472.CAN-07-3127.","journal-title":"Cancer Res"},{"key":"7915_CR87","doi-asserted-by":"publisher","unstructured":"Arina A, Idel C, Hyjek EM, Alegre M-L, Wang Y, Bindokas VP, et al. Tumor-associated fibroblasts predominantly come from local and not circulating precursors. Proc Natl Acad Sci USA. 2016;113(27):7551\u20136. https:\/\/doi.org\/10.1073\/pnas.1600363113","DOI":"10.1073\/pnas.1600363113"},{"key":"7915_CR88","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1016\/S1357-2725(02)00053-5","volume":"34","author":"A Krtolica","year":"2002","unstructured":"Krtolica A, Campisi J. Cancer and aging: a model for the cancer promoting effects of the aging stroma. Int J Biochem Cell Biol. 2002;34:1401\u201314. https:\/\/doi.org\/10.1016\/S1357-2725(02)00053-5.","journal-title":"Int J Biochem Cell Biol"},{"key":"7915_CR89","doi-asserted-by":"publisher","first-page":"3215","DOI":"10.3390\/cancers16183215","volume":"16","author":"D Vecchiotti","year":"2024","unstructured":"Vecchiotti D, Clementi L, Cornacchia E, Di Vito Nolfi M, Verzella D, Capece D, et al. Evidence of the Link between stroma remodeling and prostate cancer prognosis. Cancers. Multidisciplinary Digit Publishing Inst. 2024;16:3215. https:\/\/doi.org\/10.3390\/cancers16183215.","journal-title":"Multidisciplinary Digit Publishing Inst"},{"key":"7915_CR90","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41420-021-00450-y","volume":"7","author":"H Wang","year":"2021","unstructured":"Wang H, Zheng Q, Lu Z, Wang L, Ding L, Xia L, et al. Role of the nervous system in cancers: a review. Cell Death Discov Nat Publishing Group. 2021;7:76. https:\/\/doi.org\/10.1038\/s41420-021-00450-y.","journal-title":"Cell Death Discov Nat Publishing Group"},{"key":"7915_CR91","doi-asserted-by":"publisher","first-page":"2564","DOI":"10.1016\/j.pain.2011.07.020","volume":"152","author":"JM Jimenez-Andrade","year":"2011","unstructured":"Jimenez-Andrade JM, Ghilardi JR, Castaneda-Corral G, Kuskowski MA, Mantyh PW. Preventive or late administration of anti-NGF therapy attenuates tumor-induced nerve sprouting, neuroma formation and cancer pain. Pain. 2011;152:2564\u201374. https:\/\/doi.org\/10.1016\/j.pain.2011.07.020.","journal-title":"Pain"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-07915-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07915-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-07915-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T11:42:37Z","timestamp":1773315757000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-07915-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["7915"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-07915-7","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"13 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Declaration of Helsinki and approved by the ethical Committees (PC-StAR Project; University \u2018L. Vanvitelli\u2019 B.684; 18\/12\/2017). Informed consent was obtained from all subjects for experimentation in human subjects.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"356"}}